Related Experiment Video
Updated: Jul 27, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Mutation in the Common Docking Domain Affects MAP Kinase ERK2 Catalysis and Stability
Leonore Novak1, Maria Petrosino2, Alessandra Pasquo3
1Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza University of Rome, 00185 Rome, Italy.
Abstract:
The extracellular-signal-regulated kinase 2 (ERK2), a mitogen-activated protein kinase (MAPK) located downstream of the Ras-Raf-MEK-ERK signal transduction cascade, is involved in the regulation of a large variety of cellular processes. The ERK2, activated by phosphorylation, is the principal effector of a central signaling cascade that converts extracellular stimuli into cells. Deregulation of the ERK2 signaling pathway is related to many human diseases, including cancer. This study reports a comprehensive biophysical analysis of structural, function, and stability data of pure, recombinant human non-phosphorylated (NP-) and phosphorylated (P-) ERK2 wild-type and missense variants in the common docking site (CD-site) found in cancer tissues. Because the CD-site is involved in interaction with protein substrates and regulators, a biophysical characterization of missense variants adds information about the impact of point mutations on the ERK2 structure-function relationship. Most of the P-ERK2 variants in the CD-site display a reduced catalytic efficiency, and for the P-ERK2 D321E, D321N, D321V and E322K, changes in thermodynamic stability are observed. The thermal stability of NP-ERK2 and P-ERK2 D321E, D321G, and E322K is decreased with respect to the wild-type. In general, a single residue mutation in the CD-site may lead to structural local changes that reflects in alterations in the global ERK2 stability and catalysis.
Insights
Mutations in the ERK2 docking site impact its function and stability. This study analyzes how these changes affect cancer-related signaling pathways, revealing potential therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Signaling
Background:
- Extracellular-signal-regulated kinase 2 (ERK2) is a key mitogen-activated protein kinase (MAPK) in the Ras-Raf-MEK-ERK pathway.
- ERK2 signaling is crucial for cellular processes and its deregulation is linked to human diseases, notably cancer.
- The common docking site (CD-site) of ERK2 is vital for substrate and regulator interactions.
Purpose of the Study:
- To conduct a comprehensive biophysical analysis of wild-type and variant human ERK2 (non-phosphorylated and phosphorylated).
- To investigate the impact of missense mutations in the ERK2 CD-site on its structure, function, and stability.
- To understand how point mutations affect the ERK2 structure-function relationship in the context of cancer.
Main Methods:
- Purification of recombinant human non-phosphorylated (NP-) and phosphorylated (P-) ERK2 wild-type and missense variants.
- Comprehensive biophysical analysis including structural, functional, and stability assays.
- Characterization of variants located in the common docking site (CD-site).
Main Results:
- Most P-ERK2 variants in the CD-site exhibited reduced catalytic efficiency.
- Specific variants (P-ERK2 D321E, D321N, D321V, E322K) showed altered thermodynamic stability.
- Thermal stability was decreased in NP-ERK2 and P-ERK2 variants (D321E, D321G, E322K) compared to wild-type.
Conclusions:
- Single residue mutations in the ERK2 CD-site can induce local structural changes.
- These structural alterations lead to changes in global ERK2 stability and catalytic activity.
- Understanding these mutations' effects is crucial for deciphering ERK2's role in disease and developing targeted therapies.
Related Concept Videos
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

